Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Amortizatization of Intangibles for 14 consecutive years, with -$20000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 96.84% year-over-year to -$20000.0, compared with a TTM value of $109000.0 through Dec 2025, down 86.03%, and an annual FY2025 reading of -$503000.0, down 144.2% over the prior year.
  • Amortizatization of Intangibles was -$20000.0 for Q4 2025 at Enanta Pharmaceuticals, down from $958000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.4 million in Q2 2023 and bottomed at -$816000.0 in Q1 2025.
  • Average Amortizatization of Intangibles over 5 years is $30750.0, with a median of -$39000.0 recorded in 2022.
  • The sharpest move saw Amortizatization of Intangibles soared 1778.12% in 2024, then plummeted 3164.0% in 2025.
  • Year by year, Amortizatization of Intangibles stood at -$546000.0 in 2021, then surged by 162.09% to $339000.0 in 2022, then plummeted by 180.83% to -$274000.0 in 2023, then plummeted by 130.66% to -$632000.0 in 2024, then skyrocketed by 96.84% to -$20000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ENTA at -$20000.0 in Q4 2025, $958000.0 in Q3 2025, and -$13000.0 in Q2 2025.